U.S. flag

An official website of the United States government

NM_000551.4(VHL):c.256C>G (p.Pro86Ala) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 12, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001227827.10

Allele description [Variation Report for NM_000551.4(VHL):c.256C>G (p.Pro86Ala)]

NM_000551.4(VHL):c.256C>G (p.Pro86Ala)

Gene:
VHL:von Hippel-Lindau tumor suppressor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p25.3
Genomic location:
Preferred name:
NM_000551.4(VHL):c.256C>G (p.Pro86Ala)
HGVS:
  • NC_000003.12:g.10142103C>G
  • NG_008212.3:g.5469C>G
  • NM_000551.4:c.256C>GMANE SELECT
  • NM_001354723.2:c.256C>G
  • NM_198156.3:c.256C>G
  • NP_000542.1:p.Pro86Ala
  • NP_001341652.1:p.Pro86Ala
  • NP_937799.1:p.Pro86Ala
  • LRG_322t1:c.256C>G
  • LRG_322:g.5469C>G
  • LRG_322p1:p.Pro86Ala
  • NC_000003.11:g.10183787C>G
  • NM_000551.3:c.256C>G
  • P40337:p.Pro86Ala
  • p.[Pro86Ala]
Protein change:
P86A
Links:
UniProtKB: P40337#VAR_005693; dbSNP: rs398123481
NCBI 1000 Genomes Browser:
rs398123481
Molecular consequence:
  • NM_000551.4:c.256C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354723.2:c.256C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198156.3:c.256C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Chuvash polycythemia
Synonyms:
POLYCYTHEMIA, VHL-DEPENDENT; Erythrocytosis, familial, 2
Identifiers:
MONDO: MONDO:0009892; MedGen: C1837915; Orphanet: 238557; OMIM: 263400
Name:
Von Hippel-Lindau syndrome (VHLS)
Synonyms:
VHL syndrome; Von Hippel-Lindau
Identifiers:
MONDO: MONDO:0008667; MedGen: C0019562; Orphanet: 892; OMIM: 193300

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001400203Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 12, 2019)
germlineclinical testing

PubMed (11)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Clinical and molecular characteristics of East Asian patients with von Hippel-Lindau syndrome.

Wong M, Chu YH, Tan HL, Bessho H, Ngeow J, Tang T, Tan MH.

Chin J Cancer. 2016 Aug 15;35(1):79. doi: 10.1186/s40880-016-0141-z.

PubMed [citation]
PMID:
27527340
PMCID:
PMC4986176

Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma.

Olschwang S, Richard S, Boisson C, Giraud S, Laurent-Puig P, Resche F, Thomas G.

Hum Mutat. 1998;12(6):424-30.

PubMed [citation]
PMID:
9829912
See all PubMed Citations (11)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001400203.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (11)

Description

This sequence change replaces proline with alanine at codon 86 of the VHL protein (p.Pro86Ala). The proline residue is highly conserved and there is a small physicochemical difference between proline and alanine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with clinical features of von Hippel-Lindau syndrome (PMID: 17102082, 27034144, 7728151, Invitae). It has also been observed to segregate with disease in related individuals. This variant is also known as c.469C>G in the literature. ClinVar contains an entry for this variant (Variation ID: 93327). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant disrupts the p.Pro86 amino acid residue in VHL. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 8634692, 9829912, 19464396, 27057652, 27527340, 11257211, 19408298). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024